Author

Z. Rankovic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

T. Chen· 2 shared W. Lin· 2 shared A. A. Shelat· 1 shared A. Abdolvahabi· 1 shared A. Abu-Zaid· 1 shared A. AlTahan· 1 shared A. Broniscer· 1 shared A. Davidoff· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

T. Chen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Sonic Hedgehog Activates Prostaglandin Signaling to Stabilize Primary Cilium Length

S. S. Ansari, M. E. Dillard, Y. Zhang, M. A. Austria, N. Boatwright, E. L. Shelton, A. Johnson, B. M. Young, Z. Rankovic, J. D. Schuetz, C. G. Robinson, S. K. Ogden

This study shows SHH signaling stabilizes primary cilium length through crosstalk with EP4 prostaglandin signaling, ensuring proper SHH pathway function.

bioRxiv · May 6, 2022Cell Biology

Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response

C. He, K. Xu, X. Zhu, P. S. Dunphy, B. Gudenas, W. Lin, N. Twarog, L. D. Hover, C.-H. Kwon, L. H. Kasper, J. Zhang, X. Li, J. Dalton, B. Jonchere, K. S. Mercer, , S. J. Baker

The paper establishes patient-derived orthotopic xenograft models and cell lines from pediatric high-grade glioma that replicate histopathology, molecular signatures, and drug response, providing a resource for research.

bioRxiv · Dec 6, 2020 · PreprintCancer Biology

Geldanamycin inhibits Jumonji histone lysine demethylase KDM4 and targets chimeric transcription factor PAX3-FOXO1

A. Abu-Zaid, S. Singh, W. LIN, J. Low, A. Abdolvahabi, B. Bailey Cooke, J. Bowling, S. Vaithiyalingam, J. Fang, D. Currier, M.-K. Yun, A. AlTahan, D. Fernando, J. Maier, H. Tillman, , J. YANG

This study identifies geldanamycin and its analog 17-DMAG as dual KDM/Hsp90 inhibitors effective against PAX3-FOXO1-driven rhabdomyosarcoma.

bioRxiv · Dec 11, 2019 · PreprintCancer Biology